BUSINESS

• Ultragenyx’s LC-FAOD Therapy Dojolvi Now Available in Japan
  May 22, 2026

• SanBio Debuts Akuugo Stem Cell Therapy for Traumatic Brain Injury
  May 22, 2026

• BMS, Nikon Pitch Japan-to-Asia Cell Therapy Push, Draw Support at Policy Forum
  May 21, 2026

• Fuji Plans July Launch for Japan’s 1st Simponi, Ranmark Biosimilars
  May 21, 2026

• Myelofibrosis Med Inrebic to Go on Sale June 1: Recordati Japan
  May 21, 2026

• Fujifilm Opens New US Facility, Expands iPSC-Derived Cell Production
  May 21, 2026

• High-Dose Uptravi Now Available: Nippon Shinyaku
  May 21, 2026

• Sanofi Eyes Double-Digit Annual Growth for Japan Vaccine Business: Exec
  May 20, 2026

• Takeda Hit with Massive Damages Verdict in US Amitiza Antitrust Case
  May 20, 2026

• Top Generic Makers Grow Sales on Higher Output, Shipment Recovery
  May 20, 2026

• Tapinarof Cream Logs Positive Data in Infant Atopic Dermatitis: Shionogi
  May 20, 2026

• Bayer Files FXIa Inhibitor Asundexian in Japan
  May 20, 2026

• Japan’s Big 4 Drug Wholesalers See Profit Pressure Intensify in FY2025
  May 19, 2026

• Asahi Kasei Starts Japan PIII of Extended Teribone Dosing
  May 19, 2026

• Allergan Files Botox Vista for Forehead Wrinkles
  May 19, 2026

• Stella Begins Japan PIII of BNCT for Recurrent Glioblastoma
  May 19, 2026

• Enhertu Earns 2 US Approvals in HER2-Positive Early Breast Cancer
  May 19, 2026

• Kissei Urges Halt to New Tavneos Use after Fatal Liver Injury Reports
  May 18, 2026

• Eisai Hits Record Sales as Leqembi Revenue Nearly Doubles in FY2025
  May 18, 2026

• Kaken Files Vascular Malformation Drug in Japan, Eyes FY2027 Approval
  May 18, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »